Market Cap

Pharmanutra S.p.A. Market Capitalization:

€447.4 Million

EUR as of July 1, 2025

US$528.3 Million

business Pharmanutra S.p.A. Company Profile

Pharmanutra S.p.A. Main Stock Listing

MTA: PHN

Market Capitalization History of Pharmanutra S.p.A.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $70.87 B
MERCK Kommanditgesellschaft auf Aktien $55.96 B
Takeda Pharmaceutical Company Limited $48.34 B
Haleon plc $46.46 B
Hansoh Pharmaceutical Group Company Ltd $23.59 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $699.59 B
Johnson & Johnson $374.29 B
AbbVie $336.94 B
Novo Nordisk $309.91 B
UnitedHealth Group $279.90 B

Yearly evolution of Pharmanutra S.p.A. market cap

Date Market Cap YoY Change
Jan. 1, 2025 €501.5 M -7.36%
Jan. 1, 2024 €541.4 M -11.81%
Jan. 1, 2023 €613.9 M -4.85%
Jan. 1, 2022 €645.1 M 75.07%
Jan. 1, 2021 €368.5 M 61.80%
Jan. 1, 2020 €227.8 M 37.87%
Jan. 1, 2019 €165.2 M 37.96%
Jan. 1, 2018 €119.7 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Pharmanutra S.p.A. Categories

Italy languages Healthcare languages Drug Manufacturers—Specialty & Generic
Italy Healthcare Italy Drug Manufacturers—Specialty & Generic

Stocks & Indices

Pharmanutra S.p.A. has the following listings and related stock indices.


Stock: MTA: PHN

Stock: FSX: 761

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.